Lucie Turcotte

Aug 6, 2024 | healio.com | Matthew Shinkle |Mindy Valcarcel |Lucie Turcotte

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: Recipients of cells from donors with low socioeconomic status had shorter OS. Researchers hope to explore if this relationship exists among children.

Jul 17, 2024 | cancer.umn.edu | Lucie Turcotte

Published in PNAS, a research team led by Masonic Cancer Center and University of Minnesota Medical School scientists demonstrated that the socioeconomic status (SES) of cell donors affects the health outcomes of blood cancer patients who underwent hematopoietic cell transplantation (HCT). The study examined the health outcomes of 2,005 blood cancer patients treated with HCT across 125 hospitals in the United States.

May 8, 2024 | cancer.umn.edu | Lucie Turcotte

After a cancer diagnosis there is often a lifelong change to health and lifestyle that have long term consequences for a cancer survivor, their families, and loved ones. At the Masonic Cancer Center, University of Minnesota, we’re committed to providing valuable research, resources, and information into cancer survivorship—from the point of diagnosis to far beyond.

Mar 12, 2024 | startribune.com | Lucie Turcotte

Opinion editor's note: Star Tribune Opinion publishes a mix of national and local commentaries online and in print each day. To contribute, click here. ??? In January of last year, a young patient and her family sat in my office confronting the heartbreaking news of her cancer diagnosis. Urgent treatment was crucial, given the potential airway compromise associated with Hodgkins lymphoma.

Mar 7, 2024 | nature.com | Todd Gibson |Stephen W. Hartley |Wendy M. Leisenring |Lucie Turcotte |Stephen J. Chanock

AbstractSurvivors of childhood cancer are at increased risk for subsequent cancers attributable to the late effects of radiotherapy and other treatment exposures; thus, further understanding of the impact of genetic predisposition on risk is needed.